Archive for January 2012
Cell Based Reporter Assays vs. Animal Studies in Drug Discovery- Potential Limitations, Risks and Liabilities
Posted by: sciclips on: January 16, 2012
This blog critically analyzes the potential scientific limitations, risks and liabilities of cell based reporter assays, including non-natural protein based reporter assays (e.g. circularly permuted firefly luciferase or GFP reporter assays) and stem cell based assays, in drug discovery and development. Scientific arguments have been put forward to suggest that current format of cell based [...]
Sciclips Consultancy Services
Posted by: sciclips on: January 15, 2012
Fostering innovation through scientific intelligence Sciclips consultancy service team is comprised of highly qualified and experienced scientists who have several years of research experience in academic and industrial laboratories. We offer following custom services at competitive price: Scientific and technical areas covered: Drug discovery, Stem cells, Genomics, Proteomics, Biomarkers, Clinical diagnostics, Companion diagnostics, Molecular diagnostics, [...]
Cancer Theranostics – Potential Applications of Cancer Biomarker Database
Posted by: sciclips on: January 9, 2012
- In: Biomarkers | Drug discovery | Drug targets | miRNA | Proteomics
- Leave a Comment
Availability of a comprehensive cancer biomarker database may opens up scientific and technical opportunities in developing innovative oncologic theranostics (Rx/Dx), a diagnostic therapy process that leads to the development of successful personalized medicine strategies in cancer treatment. With the growing trend towards the advancement of personalized medicine concept, there is a need to develop strategies [...]
Recent Comments